Skip to content
OpenCapital
Get started

Chemed CHE Operating Lease Liability Payments - 2028 (Lessee)

Other financials

Income statement

See full
Revenue$657.5M+1.6%
Gross profit$215.8M-0.3%
Operating income$84.6M-10.7%
Net income$66.3M-7.6%
EPS (diluted)$4.84-0.4%

Balance sheet

See full
Cash & equivalents$16.9M-90.3%
Total debt$236.9M+63.3%
Total equity$848.0M-28.2%
Total assets$1.5B-11.0%

Cash flow

See full
Operating cash flow$88.2M+169%
CapEx$17.1M+28.9%
Free cash flow$71.1M+265%

Valuation

See full
Market cap$5.79B-42.3%
Enterprise value$6.01B-39.6%
P/E22.3×-10.2×
P/S2.3×-1.8×

Profitability

See full
Gross margin32.4%-2.4pp
Operating margin12.9%-2.7pp
Net margin10.2%-2.2pp
FCF margin14.8%+2.2pp

Returns & leverage

See full
Return on equity25.6%-0.5pp
Debt / equity0.3×+0.2×
Current ratio0.9×-0.9×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour.

The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's operating lease liability payments - 2028 (lessee).

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemed's operating lease liability payments - 2028 (lessee)?
Chemed (CHE) reported operating lease liability payments - 2028 (lessee) of $15.95M in Q1 2026.
How has Chemed's operating lease liability payments - 2028 (lessee) changed year-over-year?
Chemed's operating lease liability payments - 2028 (lessee) increased by 6.6% year-over-year, from $14.97M to $15.95M.
What is the long-term trend for Chemed's operating lease liability payments - 2028 (lessee)?
Over 5 years (2020 to 2025), Chemed's operating lease liability payments - 2028 (lessee) has grown at a 2.5% compound annual growth rate (CAGR), from $18.24M to $20.66M.